Evidence map›Paper›PMID 42401584›Full record

ArticleNature communications2026

Joint trajectories of brain atrophy, white matter hyperintensities and cognition quantify brain maintenance.

Inga Menze, Jose Bernal, Rogier A Kievit, Kumar Parijat Tripathi, Timo Kaleck, Renat Yakupov, Slawek Altenstein, Claudia Bartels, Katharina Buerger, Michaela Butryn and 39 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

49 authors.

Inga MenzeGerman Centre for Neurodegenerative Diseases (DZNE), Magdeburg, Germany. inga.menze@dzne.de.ORCID 0009-0001-4567-1655
Jose BernalGerman Centre for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.ORCID 0000-0003-3167-5134
Rogier A KievitDonders Institute for Brain, Cognition and Behavior, Radboud University Medical Centre, Nijmegen, The Netherlands.
Kumar Parijat TripathiDivision of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID 0000-0002-3998-599X
Timo KaleckDivision of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Renat YakupovGerman Centre for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.ORCID 0000-0002-3868-284X
Slawek AltensteinGerman Centre for Neurodegenerative Diseases (DZNE), Berlin, Germany.
Claudia BartelsDepartment of Psychiatry and Psychotherapy, University Medical Centre Goettingen, Georg August University of Goettingen, Goettingen, Germany.
Katharina BuergerGerman Centre for Neurodegenerative Diseases (DZNE), Munich, Germany.
Michaela ButrynGerman Centre for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Peter DechentMR-Research in Neurosciences, Department of Cognitive Neurology, University Medical Centre Goettingen, Goettingen, Germany.
Michael EwersGerman Centre for Neurodegenerative Diseases (DZNE), Munich, Germany.ORCID 0000-0001-5231-1714
Klaus FliessbachGerman Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Ingo FrommannGerman Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID 0000-0002-7244-2014
Maria GemenetziGerman Centre for Neurodegenerative Diseases (DZNE), Berlin, Germany.
Wenzel GlanzGerman Centre for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Daria GrefDepartment of Psychiatry and Neurosciences, Charité Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0003-2497-9324
Julian Hellmann-RegenGerman Centre for Neurodegenerative Diseases (DZNE), Berlin, Germany.ORCID 0000-0003-0411-9204
Stefan HetzerBerlin Centre for Advanced Neuroimaging, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Enise I IncesoyGerman Centre for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Daniel JanowitzGerman Centre for Neurodegenerative Diseases (DZNE), Munich, Germany.
Ingo KilimanGerman Centre for Neurodegenerative Diseases (DZNE), Rostock, Germany.
Luca KleineidamGerman Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID 0009-0006-3309-6856
Marie Theres KronmüllerGerman Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Christoph LaskeGerman Centre for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Debora Melo van LentGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, UT Health San Antonio, San Antonio, TX, USA.ORCID 0000-0002-7392-9289
Falk LüsebrinkGerman Centre for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Robert PerneczkyGerman Centre for Neurodegenerative Diseases (DZNE), Munich, Germany.ORCID 0000-0003-1981-7435
Oliver PetersGerman Centre for Neurodegenerative Diseases (DZNE), Berlin, Germany.ORCID 0000-0003-0568-2998
Lukas PreisDepartment of Psychiatry and Neurosciences, Charité Universitätsmedizin Berlin, Berlin, Germany.
Josef PrillerInstitute for Neuroscience and Cardiovascular Research, Row Fogo Centre for Research into Ageing and The Brain, Department of Neuroimaging Sciences, The University of Edinburgh, Edinburgh, UK.ORCID 0000-0001-7596-0979
Boris-Stephan RauchmannDepartment of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0003-4547-6240
Ayda RostamzadehDepartment of Psychiatry, University of Cologne, Medical Faculty, Cologne, Germany.
Sandra RoeskeGerman Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Klaus SchefflerDepartment for Biomedical Magnetic Resonance, University of Tübingen, Tübingen, Germany.
Björn-Hendrik SchottDepartment of Psychiatry and Psychotherapy, University Medical Centre Goettingen, Georg August University of Goettingen, Goettingen, Germany.ORCID 0000-0002-8237-4481
Anja SchneiderGerman Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID 0000-0001-9540-8700
Sebastian SodenkampGerman Centre for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Annika SpottkeGerman Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Eike Jakob SpruthGerman Centre for Neurodegenerative Diseases (DZNE), Berlin, Germany.
Melina StarkGerman Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID 0009-0005-3812-023X
Stefan TeipelGerman Centre for Neurodegenerative Diseases (DZNE), Rostock, Germany.
Michael WagnerGerman Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID 0000-0003-2589-6440
Jens WiltfangDepartment of Psychiatry and Psychotherapy, University Medical Centre Goettingen, Georg August University of Goettingen, Goettingen, Germany.ORCID 0000-0003-1492-5330
Frank JessenGerman Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Alfredo RamirezDivision of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID 0000-0003-4991-763X
Stefanie SchreiberGerman Centre for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.ORCID 0000-0003-4439-4374
Emrah DüzelGerman Centre for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Gabriel ZieglerGerman Centre for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.ORCID 0000-0001-6589-6416

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain maintenance - the preservation of brain structure or function relevant to cognitive performance - remains challenging to quantify. Here, we propose a domain-general brain maintenance index derived by jointly modelling the longitudinal co-evolution of ageing-related atrophy (via medial temporal lobe to ventricle ratio, MTLV-ratio), white matter hyperintensities (WMH), and global cognition assessed by the preclinical Alzheimer's cognitive composite (PACC5) using latent growth curve modelling. We demonstrate its utility in 543 cognitively unimpaired older adults from the DELCODE cohort, followed annually over four years. We show that changes in MTLV-ratio and WMH additively predict cognitive change. We further show that higher neuroticism, depressive symptoms, lower openness, and faster biological ageing are related to unfavourable domain-specific trajectories and poorer brain maintenance. Our findings highlight the combined relevance of WMH and ageing-related atrophy dynamics for brain maintenance. Maintaining cerebrovascular and mental health alongside cognitive engagement could promote brain maintenance, delay cognitive decline and dementia.

Indexed as

AgingBrainCognitionWhite MatterAgedAged, 80 and overAtrophyCognitive DysfunctionFemaleHumansMagnetic Resonance ImagingMale

Identifiers

PMID42401584
PMCPMC13332871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.